KNSA - CIK 0001730430
Kiniksa Pharmaceuticals, Ltd. has filed 733 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (335 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-26 | 2026-05-21 |
| SCHEDULE 13D/A | - | 2026-05-26 | - |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| Insider trade | 4 | 2026-05-05 | 2026-05-01 |
| Insider sale notice | 144 | 2026-05-01 | - |
| Major company event | 8-K | 2026-05-01 | 2026-04-30 |
| Insider trade | 4 | 2026-05-01 | 2026-05-01 |
| Insider trade | 4 | 2026-04-30 | 2026-04-28 |
| Insider trade | 4 | 2026-04-29 | 2026-04-28 |
| Insider sale notice | 144 | 2026-04-28 | - |
| Major company event | 8-K | 2026-04-28 | 2026-04-28 |
| Quarterly report | 10-Q | 2026-04-28 | 2026-03-31 |
| Annual report to shareholders | ARS | 2026-04-16 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-16 | - |
| Proxy statement | DEF 14A | 2026-04-16 | 2026-05-19 |
| Insider trade | 4 | 2026-04-13 | 2026-04-09 |
| Insider trade | 4 | 2026-04-13 | 2026-04-09 |
| Insider sale notice | 144 | 2026-04-09 | - |
| Insider sale notice | 144 | 2026-04-09 | - |
| Insider trade | 4 | 2026-04-08 | 2026-04-07 |
| Insider trade | 4 | 2026-04-08 | 2026-04-06 |
| Insider trade | 4 | 2026-04-08 | 2026-04-07 |
| Insider trade | 4 | 2026-04-08 | 2026-04-07 |
| Insider trade | 4 | 2026-04-08 | 2026-04-06 |
| Insider trade | 4 | 2026-04-08 | 2026-04-07 |
| Insider trade | 4 | 2026-04-08 | 2026-04-06 |
| Insider sale notice | 144 | 2026-04-06 | - |
| Insider sale notice | 144 | 2026-04-06 | - |
| Insider sale notice | 144 | 2026-04-06 | - |
| Insider trade | 4 | 2026-04-03 | 2026-01-15 |
| Insider trade | 4 | 2026-04-03 | 2026-01-15 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-04-03 | 2026-01-15 |
| SCHEDULE 13G/A | - | 2026-03-27 | - |
| Insider trade | 4 | 2026-03-11 | 2026-03-09 |
| Insider sale notice | 144 | 2026-03-09 | - |
| SCHEDULE 13G | - | 2026-03-06 | - |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider sale notice | 144 | 2026-03-02 | - |
| Major company event | 8-K | 2026-02-24 | 2026-02-24 |
| Employee stock plan | S-8 | 2026-02-24 | - |
| Annual report | 10-K | 2026-02-24 | 2025-12-31 |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| Insider trade | 4 | 2026-02-12 | 2026-02-10 |
| Insider trade | 4 | 2026-02-11 | 2026-02-09 |
| Insider trade | 4 | 2026-02-04 | 2026-02-01 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Major company event | 8-K | 2026-01-14 | 2026-01-10 |